ImmunityBio, Inc.IBRXNASDAQ
Loading
Gross Profit Over TimeExpanding
Percentile Rank100
3Y CAGR+658.5%
5Y CAGR+180.3%
Studio
Year-over-Year Change

Revenue minus cost of goods sold

3Y CAGR
+658.5%/yr
vs -47.5%/yr prior
5Y CAGR
+180.3%/yr
Recent acceleration
Acceleration
+706.0pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
173.1x
Strong expansion
Streak
3 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$104.72M+610.2%
2024$14.74M+2270.6%
2023$622000.00+159.2%
2022$240000.00-74.3%
2021$934000.00+54.4%
2020$605000.00+106.7%
2019$-8.97M-384.1%
2018$3.16M+6915.6%
2017$45000.00+2.3%
2016$44000.00-